Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 63 | 2026 | 2247 | 8.200 |
Why?
|
| Thalamic Nuclei | 20 | 2026 | 28 | 7.900 |
Why?
|
| Image Processing, Computer-Assisted | 28 | 2026 | 699 | 6.020 |
Why?
|
| Image Enhancement | 28 | 2019 | 193 | 4.410 |
Why?
|
| Image Interpretation, Computer-Assisted | 23 | 2020 | 188 | 3.420 |
Why?
|
| Imaging, Three-Dimensional | 19 | 2019 | 300 | 3.260 |
Why?
|
| White Matter | 11 | 2025 | 128 | 3.220 |
Why?
|
| Neuroimaging | 5 | 2026 | 165 | 2.800 |
Why?
|
| Brain Mapping | 9 | 2026 | 240 | 2.720 |
Why?
|
| Thalamus | 9 | 2026 | 77 | 2.500 |
Why?
|
| Algorithms | 28 | 2026 | 1050 | 2.110 |
Why?
|
| Gray Matter | 3 | 2025 | 39 | 1.910 |
Why?
|
| Signal Processing, Computer-Assisted | 8 | 2017 | 99 | 1.550 |
Why?
|
| Alzheimer Disease | 6 | 2025 | 766 | 1.530 |
Why?
|
| Multiple Sclerosis | 9 | 2024 | 227 | 1.400 |
Why?
|
| Alcoholism | 8 | 2025 | 329 | 1.370 |
Why?
|
| Echo-Planar Imaging | 7 | 2016 | 34 | 1.340 |
Why?
|
| Brain | 9 | 2025 | 1611 | 1.140 |
Why?
|
| Artifacts | 9 | 2018 | 128 | 1.140 |
Why?
|
| Cognitive Dysfunction | 5 | 2025 | 350 | 1.020 |
Why?
|
| Connectome | 2 | 2026 | 38 | 0.990 |
Why?
|
| Humans | 89 | 2026 | 65498 | 0.990 |
Why?
|
| Sensitivity and Specificity | 22 | 2017 | 1172 | 0.940 |
Why?
|
| Movement Disorders | 1 | 2025 | 26 | 0.920 |
Why?
|
| Female | 59 | 2026 | 34216 | 0.900 |
Why?
|
| Adult | 43 | 2026 | 17467 | 0.890 |
Why?
|
| Ventral Thalamic Nuclei | 3 | 2020 | 7 | 0.890 |
Why?
|
| Male | 54 | 2026 | 31208 | 0.880 |
Why?
|
| Reproducibility of Results | 21 | 2025 | 1710 | 0.870 |
Why?
|
| Magnetic Resonance Angiography | 10 | 2011 | 186 | 0.860 |
Why?
|
| Frontotemporal Dementia | 1 | 2025 | 157 | 0.780 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2026 | 165 | 0.760 |
Why?
|
| Data Compression | 4 | 2018 | 9 | 0.760 |
Why?
|
| Essential Tremor | 5 | 2021 | 20 | 0.750 |
Why?
|
| Middle Aged | 37 | 2026 | 18393 | 0.740 |
Why?
|
| Contrast Media | 12 | 2019 | 432 | 0.710 |
Why?
|
| Schizophrenia | 1 | 2024 | 275 | 0.710 |
Why?
|
| Pulvinar | 3 | 2025 | 3 | 0.650 |
Why?
|
| Neural Pathways | 5 | 2025 | 102 | 0.640 |
Why?
|
| Kidney | 4 | 2019 | 455 | 0.640 |
Why?
|
| HIV Infections | 3 | 2024 | 957 | 0.640 |
Why?
|
| Glomerular Filtration Rate | 3 | 2019 | 121 | 0.630 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2019 | 92 | 0.610 |
Why?
|
| Back Pain | 1 | 2019 | 49 | 0.600 |
Why?
|
| Aged | 27 | 2025 | 15062 | 0.590 |
Why?
|
| Aging | 5 | 2025 | 774 | 0.580 |
Why?
|
| Atrophy | 7 | 2025 | 87 | 0.570 |
Why?
|
| Young Adult | 13 | 2026 | 4839 | 0.560 |
Why?
|
| Adipose Tissue | 4 | 2014 | 300 | 0.550 |
Why?
|
| Spine | 1 | 2018 | 55 | 0.540 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2026 | 78 | 0.540 |
Why?
|
| Breath Holding | 3 | 2015 | 7 | 0.520 |
Why?
|
| Physics | 1 | 2017 | 12 | 0.510 |
Why?
|
| Kidney Function Tests | 1 | 2017 | 36 | 0.510 |
Why?
|
| Breast Neoplasms | 6 | 2016 | 1232 | 0.480 |
Why?
|
| Abdomen | 3 | 2014 | 97 | 0.470 |
Why?
|
| Cerebellum | 3 | 2021 | 94 | 0.460 |
Why?
|
| Pattern Recognition, Automated | 3 | 2018 | 52 | 0.460 |
Why?
|
| Renal Artery | 2 | 2011 | 36 | 0.430 |
Why?
|
| Breast | 1 | 2016 | 192 | 0.420 |
Why?
|
| Myocardial Infarction | 3 | 2013 | 921 | 0.400 |
Why?
|
| Red Nucleus | 2 | 2025 | 5 | 0.390 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2013 | 8 | 0.390 |
Why?
|
| Hippocampus | 4 | 2024 | 276 | 0.380 |
Why?
|
| Deep Brain Stimulation | 3 | 2023 | 68 | 0.370 |
Why?
|
| Aged, 80 and over | 11 | 2025 | 5650 | 0.370 |
Why?
|
| Gadolinium | 2 | 2012 | 110 | 0.370 |
Why?
|
| Abdominal Neoplasms | 1 | 2012 | 22 | 0.360 |
Why?
|
| Renal Artery Obstruction | 1 | 2011 | 17 | 0.350 |
Why?
|
| Functional Laterality | 2 | 2024 | 140 | 0.350 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2018 | 175 | 0.320 |
Why?
|
| Coronary Angiography | 4 | 2005 | 212 | 0.310 |
Why?
|
| Subtraction Technique | 4 | 2013 | 24 | 0.300 |
Why?
|
| Longitudinal Studies | 4 | 2025 | 1285 | 0.300 |
Why?
|
| Liver Neoplasms | 3 | 2018 | 308 | 0.300 |
Why?
|
| Cerebral Cortex | 2 | 2025 | 269 | 0.300 |
Why?
|
| Liver Diseases | 2 | 2015 | 157 | 0.290 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2007 | 115 | 0.290 |
Why?
|
| Atlases as Topic | 2 | 2026 | 14 | 0.280 |
Why?
|
| Phantoms, Imaging | 5 | 2019 | 236 | 0.280 |
Why?
|
| Neuropsychological Tests | 3 | 2025 | 412 | 0.270 |
Why?
|
| Kidney Diseases | 1 | 2009 | 178 | 0.260 |
Why?
|
| Organ Size | 2 | 2025 | 173 | 0.260 |
Why?
|
| Signal-To-Noise Ratio | 2 | 2018 | 61 | 0.240 |
Why?
|
| Basal Ganglia | 1 | 2025 | 34 | 0.230 |
Why?
|
| Tremor | 1 | 2025 | 25 | 0.230 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 1 | 2025 | 7 | 0.230 |
Why?
|
| Cluster Analysis | 1 | 2026 | 267 | 0.220 |
Why?
|
| Benchmarking | 1 | 2026 | 137 | 0.220 |
Why?
|
| Amygdala | 1 | 2025 | 85 | 0.220 |
Why?
|
| Postural Balance | 1 | 2025 | 67 | 0.220 |
Why?
|
| Heart Ventricles | 2 | 2005 | 267 | 0.210 |
Why?
|
| Gadolinium DTPA | 4 | 2013 | 84 | 0.210 |
Why?
|
| Body Water | 2 | 2014 | 15 | 0.210 |
Why?
|
| Attention | 1 | 2024 | 154 | 0.190 |
Why?
|
| Case-Control Studies | 3 | 2021 | 1143 | 0.190 |
Why?
|
| Liver | 3 | 2016 | 871 | 0.190 |
Why?
|
| Epilepsy | 1 | 2023 | 113 | 0.180 |
Why?
|
| Memory, Episodic | 1 | 2021 | 21 | 0.170 |
Why?
|
| Respiratory Mechanics | 2 | 2011 | 56 | 0.170 |
Why?
|
| Reference Values | 3 | 2014 | 328 | 0.170 |
Why?
|
| Prodromal Symptoms | 1 | 2021 | 13 | 0.170 |
Why?
|
| Computer Simulation | 3 | 2015 | 485 | 0.160 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2020 | 5 | 0.160 |
Why?
|
| High-Intensity Focused Ultrasound Ablation | 1 | 2020 | 5 | 0.160 |
Why?
|
| Alcohol Abstinence | 1 | 2021 | 15 | 0.160 |
Why?
|
| Coronary Vessels | 4 | 2003 | 125 | 0.160 |
Why?
|
| Respiration | 6 | 2018 | 95 | 0.160 |
Why?
|
| Heart | 1 | 2002 | 298 | 0.160 |
Why?
|
| Automation | 1 | 2020 | 55 | 0.160 |
Why?
|
| Cerebellar Nuclei | 1 | 2020 | 4 | 0.160 |
Why?
|
| Stereotaxic Techniques | 1 | 2020 | 30 | 0.160 |
Why?
|
| Reflex, Stretch | 1 | 2019 | 2 | 0.160 |
Why?
|
| Lymphography | 1 | 2020 | 11 | 0.160 |
Why?
|
| Urography | 2 | 2017 | 13 | 0.160 |
Why?
|
| Lymphatic Abnormalities | 1 | 2020 | 5 | 0.160 |
Why?
|
| Learning | 1 | 2021 | 186 | 0.150 |
Why?
|
| Motion | 2 | 2018 | 65 | 0.150 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2019 | 1 | 0.150 |
Why?
|
| Aging, Premature | 1 | 2019 | 2 | 0.150 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2019 | 4 | 0.150 |
Why?
|
| Cohort Studies | 1 | 2025 | 2633 | 0.150 |
Why?
|
| Renal Insufficiency | 1 | 2019 | 68 | 0.140 |
Why?
|
| Prospective Studies | 3 | 2016 | 3326 | 0.140 |
Why?
|
| Child | 5 | 2020 | 4623 | 0.130 |
Why?
|
| Adolescent | 7 | 2025 | 6333 | 0.130 |
Why?
|
| Sex Factors | 1 | 2019 | 995 | 0.120 |
Why?
|
| Leiomyoma | 1 | 2016 | 18 | 0.120 |
Why?
|
| Poisson Distribution | 1 | 2016 | 52 | 0.120 |
Why?
|
| Uterine Neoplasms | 1 | 2016 | 36 | 0.120 |
Why?
|
| Retrospective Studies | 6 | 2020 | 6939 | 0.120 |
Why?
|
| Organometallic Compounds | 2 | 2014 | 71 | 0.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1996 | 278 | 0.110 |
Why?
|
| Meglumine | 1 | 2014 | 21 | 0.110 |
Why?
|
| Pancreas | 1 | 2015 | 153 | 0.110 |
Why?
|
| Lateral Thalamic Nuclei | 1 | 2014 | 1 | 0.110 |
Why?
|
| Knee Joint | 2 | 2019 | 312 | 0.100 |
Why?
|
| Magnetics | 1 | 2014 | 53 | 0.100 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2013 | 13 | 0.100 |
Why?
|
| Entorhinal Cortex | 1 | 2013 | 8 | 0.100 |
Why?
|
| Anatomic Landmarks | 1 | 2013 | 6 | 0.100 |
Why?
|
| Digestive System Diseases | 1 | 2013 | 14 | 0.100 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2013 | 10 | 0.100 |
Why?
|
| Single-Blind Method | 1 | 2013 | 142 | 0.100 |
Why?
|
| Cross-Sectional Studies | 3 | 2025 | 2725 | 0.100 |
Why?
|
| Mammography | 2 | 2012 | 292 | 0.100 |
Why?
|
| Neuropil | 1 | 2012 | 6 | 0.090 |
Why?
|
| Executive Function | 2 | 2024 | 68 | 0.090 |
Why?
|
| Arteries | 1 | 2013 | 81 | 0.090 |
Why?
|
| Memory Disorders | 1 | 2012 | 52 | 0.090 |
Why?
|
| Electrodes, Implanted | 2 | 2023 | 38 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2013 | 224 | 0.090 |
Why?
|
| Sample Size | 1 | 2012 | 67 | 0.090 |
Why?
|
| Memory | 2 | 2024 | 124 | 0.090 |
Why?
|
| Cartilage, Articular | 1 | 2011 | 79 | 0.080 |
Why?
|
| Coronary Disease | 2 | 2002 | 246 | 0.080 |
Why?
|
| Bone and Bones | 1 | 2011 | 152 | 0.080 |
Why?
|
| Evoked Potentials | 1 | 2010 | 39 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 213 | 0.070 |
Why?
|
| Fourier Analysis | 3 | 2016 | 31 | 0.070 |
Why?
|
| Feasibility Studies | 3 | 2007 | 589 | 0.070 |
Why?
|
| Time Factors | 3 | 2013 | 3774 | 0.060 |
Why?
|
| Head | 1 | 2007 | 57 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 787 | 0.060 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2007 | 169 | 0.060 |
Why?
|
| Observer Variation | 2 | 2018 | 216 | 0.060 |
Why?
|
| Molecular Imaging | 1 | 2025 | 52 | 0.060 |
Why?
|
| Coronary Circulation | 1 | 2005 | 55 | 0.050 |
Why?
|
| Stroke | 1 | 2014 | 1219 | 0.050 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2005 | 13 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2015 | 2067 | 0.050 |
Why?
|
| Spin Labels | 2 | 2015 | 12 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2025 | 231 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2024 | 66 | 0.050 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2004 | 9 | 0.050 |
Why?
|
| Diaphragm | 1 | 2004 | 25 | 0.050 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2025 | 155 | 0.050 |
Why?
|
| Ventricular Function | 1 | 2002 | 22 | 0.050 |
Why?
|
| Oxides | 1 | 2002 | 36 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2002 | 65 | 0.050 |
Why?
|
| Pilot Projects | 3 | 2013 | 1021 | 0.050 |
Why?
|
| Myocardium | 1 | 2005 | 302 | 0.050 |
Why?
|
| Systole | 1 | 2002 | 109 | 0.050 |
Why?
|
| Diastole | 1 | 2002 | 90 | 0.050 |
Why?
|
| Seizures | 1 | 2023 | 141 | 0.050 |
Why?
|
| Iron | 1 | 2002 | 155 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2021 | 72 | 0.040 |
Why?
|
| Comorbidity | 1 | 2024 | 1120 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 2020 | 47 | 0.040 |
Why?
|
| Osteolysis, Essential | 1 | 2020 | 2 | 0.040 |
Why?
|
| Thoracic Duct | 1 | 2020 | 3 | 0.040 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2020 | 56 | 0.040 |
Why?
|
| Rare Diseases | 1 | 2020 | 45 | 0.040 |
Why?
|
| Lymphatic Vessels | 1 | 2020 | 32 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2019 | 64 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2015 | 742 | 0.040 |
Why?
|
| Pregnancy | 1 | 2025 | 2392 | 0.030 |
Why?
|
| Patient-Centered Care | 1 | 2000 | 265 | 0.030 |
Why?
|
| Equipment Design | 2 | 2012 | 371 | 0.030 |
Why?
|
| Cognition | 1 | 2021 | 510 | 0.030 |
Why?
|
| Pelvis | 1 | 2016 | 64 | 0.030 |
Why?
|
| Methane | 1 | 1996 | 3 | 0.030 |
Why?
|
| Models, Structural | 1 | 1996 | 25 | 0.030 |
Why?
|
| Hydrocarbons | 1 | 1996 | 10 | 0.030 |
Why?
|
| Lactates | 1 | 1996 | 28 | 0.030 |
Why?
|
| Software | 2 | 2013 | 401 | 0.030 |
Why?
|
| Hepatic Artery | 1 | 2015 | 22 | 0.030 |
Why?
|
| Multiphasic Screening | 1 | 2015 | 1 | 0.030 |
Why?
|
| Reference Standards | 1 | 2015 | 76 | 0.030 |
Why?
|
| Lactic Acid | 1 | 1996 | 75 | 0.030 |
Why?
|
| Angiography | 1 | 2015 | 154 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2015 | 181 | 0.020 |
Why?
|
| Focal Nodular Hyperplasia | 1 | 2013 | 4 | 0.020 |
Why?
|
| Lipids | 1 | 1996 | 329 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 79 | 0.020 |
Why?
|
| Mental Recall | 1 | 2012 | 95 | 0.020 |
Why?
|
| Water | 1 | 2013 | 315 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 1704 | 0.020 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2005 | 24 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 160 | 0.010 |
Why?
|
| Thorax | 1 | 2004 | 35 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2005 | 139 | 0.010 |
Why?
|
| Fibrosis | 1 | 2005 | 172 | 0.010 |
Why?
|
| Ferrosoferric Oxide | 1 | 2002 | 17 | 0.010 |
Why?
|
| Dextrans | 1 | 2002 | 46 | 0.010 |
Why?
|
| Magnetite Nanoparticles | 1 | 2002 | 29 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2002 | 606 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2003 | 555 | 0.010 |
Why?
|
| Pentetic Acid | 1 | 1997 | 33 | 0.010 |
Why?
|